A Novel Fluidic Platform for Semi‐Automated Cell Culture into Multiwell‐Like Bioreactors

In this work, we developed and characterized a novel fluidic platform that enables long-term in vitro cell culture in a semi‐automated fashion. The system is constituted by a control unit provided with a piezoelectric pump, miniaturized valves, and a microfluidic network for management and fine cont...

Full description

Bibliographic Details
Main Authors: Butera, F. (Author), Castiglioni, S. (Author), Maier, J.A.M (Author), Milani, P. (Author), Monti, A. (Author), Orecchio, F.M (Author), Pezzotta, F. (Author), Santaniello, T. (Author), Tommaso, V. (Author)
Format: Article
Language:English
Published: MDPI 2022
Subjects:
Online Access:View Fulltext in Publisher
LEADER 02775nam a2200505Ia 4500
001 10.3390-mi13070994
008 220718s2022 CNT 000 0 und d
020 |a 2072666X (ISSN) 
245 1 0 |a A Novel Fluidic Platform for Semi‐Automated Cell Culture into Multiwell‐Like Bioreactors 
260 0 |b MDPI  |c 2022 
856 |z View Fulltext in Publisher  |u https://doi.org/10.3390/mi13070994 
520 3 |a In this work, we developed and characterized a novel fluidic platform that enables long-term in vitro cell culture in a semi‐automated fashion. The system is constituted by a control unit provided with a piezoelectric pump, miniaturized valves, and a microfluidic network for management and fine control of reagents’ flow, connected to a disposable polymeric culture unit resembling the traditional multiwell‐like design. As a proof of principle, Human Umbilical Vein Endothelial Cells (HUVEC) and Human Mesenchymal Stem Cells (hMSC) were seeded and cultured into the cell culture unit. The proliferation rate of HUVEC and the osteogenic differentiation of hMSC were assessed and compared to standard culture in Petri dishes. The results obtained demonstrated that our approach is suitable to perform semi‐automated cell culture protocols, minimizing the contribution of human operators and allowing the standardization and reproducibility of the procedures. We believe that the proposed system constitutes a promising solution for the realization of user‐friendly automated control systems that will favor the standardization of cell culture processes for cell factories, drug testing, and biomedical research. © 2022 by the authors. Licensee MDPI, Basel, Switzerland. 
650 0 4 |a Automated cell 
650 0 4 |a Automation 
650 0 4 |a Bioreactors 
650 0 4 |a Cell culture 
650 0 4 |a Cell/B.E 
650 0 4 |a Cell-be 
650 0 4 |a Cell‐on‐a‐chip 
650 0 4 |a cells‐on‐a‐chip 
650 0 4 |a Controlled drug delivery 
650 0 4 |a Endothelial cells 
650 0 4 |a fluid automation 
650 0 4 |a Fluid automation 
650 0 4 |a Human mesenchymal stem cells 
650 0 4 |a Human umbilical vein endothelial cells 
650 0 4 |a Micro-bioreactor 
650 0 4 |a micro‐bioreactors 
650 0 4 |a microfluidics 
650 0 4 |a Microfluidics 
650 0 4 |a Multi wells 
650 0 4 |a Smart fluidic 
650 0 4 |a smart fluidics 
650 0 4 |a Standardization 
650 0 4 |a Stem cells 
700 1 |a Butera, F.  |e author 
700 1 |a Castiglioni, S.  |e author 
700 1 |a Maier, J.A.M.  |e author 
700 1 |a Milani, P.  |e author 
700 1 |a Monti, A.  |e author 
700 1 |a Orecchio, F.M.  |e author 
700 1 |a Pezzotta, F.  |e author 
700 1 |a Santaniello, T.  |e author 
700 1 |a Tommaso, V.  |e author 
773 |t Micromachines